Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
TNF inhibitor
DRUG CLASS:
TNF inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
thalidomide (15)
INB03 (1)
thalidomide (15)
INB03 (1)
›
Associations
(16)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor (NCT06470464)
Phase 2
Shandong First Medical University
Shandong First Medical University
Completed
Phase 2
Shandong First Medical University
Completed
Last update posted :
06/24/2024
Initiation :
11/11/2021
Primary completion :
06/16/2024
Completion :
06/16/2024
AFP
|
gemcitabine • albumin-bound paclitaxel • epirubicin • thalidomide
The Maintenance Treatment of "ITIVA" in AML Patients (NCT06256627)
Phase N/A
Henan Cancer Hospital
Henan Cancer Hospital
Recruiting
Phase N/A
Henan Cancer Hospital
Recruiting
Last update posted :
02/13/2024
Initiation :
07/11/2023
Primary completion :
03/01/2025
Completion :
05/01/2027
IL2
|
azacitidine • thalidomide
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors (NCT01661400)
Phase 1
Washington University School of Medicine
Washington University School of Medicine
Completed
Phase 1
Washington University School of Medicine
Completed
Last update posted :
01/31/2024
Initiation :
10/26/2012
Primary completion :
12/27/2023
Completion :
12/27/2023
CD34
|
cyclophosphamide • thalidomide • cyclophosphamide intravenous
Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT (NCT01242267)
Phase 1/2
Hackensack Meridian Health
Hackensack Meridian Health
Completed
Phase 1/2
Hackensack Meridian Health
Completed
Last update posted :
01/02/2023
Initiation :
05/11/2010
Primary completion :
01/20/2016
Completion :
01/20/2016
BCL2 • CD34
|
bortezomib • thalidomide • melphalan • dexamethasone injection
Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC (NCT05198856)
Phase 1/2
Qilu Hospital of Shandong University
Qilu Hospital of Shandong University
Not yet recruiting
Phase 1/2
Qilu Hospital of Shandong University
Not yet recruiting
Last update posted :
01/20/2022
Initiation :
03/10/2022
Primary completion :
03/10/2024
Completion :
12/10/2024
HER-2
|
HER-2 negative
|
oxaliplatin • thalidomide
Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00041080)
Phase 3
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Completed
Phase 3
National Cancer Institute (NCI)
Completed
Last update posted :
07/30/2019
Initiation :
02/01/2003
Primary completion :
01/01/2011
Completion :
01/01/2011
MUC16
|
tamoxifen • thalidomide • Soltamox (tamoxifen citrate)
Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003) (NCT03062800)
Phase 2
Qilu Hospital of Shandong University
Qilu Hospital of Shandong University
Unknown status
Phase 2
Qilu Hospital of Shandong University
Unknown status
Last update posted :
06/05/2019
Initiation :
12/01/2016
Primary completion :
12/01/2020
Completion :
11/01/2021
EGFR • VEGFA
|
EGFR mutation
|
cisplatin • carboplatin • pemetrexed • thalidomide
The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol (NCT03777930)
Phase 4
Shenzhen Fifth People's Hospital
Shenzhen Fifth People's Hospital
Unknown status
Phase 4
Shenzhen Fifth People's Hospital
Unknown status
Last update posted :
12/19/2018
Initiation :
12/10/2018
Primary completion :
10/10/2020
Completion :
06/10/2021
IFNG • IL6 • TNFA • IL2 • IL10 • IL17A • IL21 • IL22
|
thalidomide • megestrol
EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide (CSWOG002) (NCT03341494)
Phase 2
Fujian Cancer Hospital
Fujian Cancer Hospital
Unknown status
Phase 2
Fujian Cancer Hospital
Unknown status
Last update posted :
11/14/2017
Initiation :
04/01/2017
Primary completion :
11/01/2019
Completion :
11/01/2020
EGFR
|
EGFR mutation • EGFR L858R • EGFR exon 19 deletion
|
gefitinib • thalidomide
Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide (NCT00899080)
Phase N/A
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Completed
Phase N/A
Eastern Cooperative Oncology Group
Completed
Last update posted :
05/17/2017
Initiation :
07/04/2008
Primary completion :
08/04/2008
Completion :
08/04/2008
CTSG
|
lenalidomide • thalidomide
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login